“SIGNALLING PATHWAYS AND MOLECULAR TARGETS FOR SKIN CANCER: INVOLVEMENT OF CDK2 INHIBITION”. Nirma University Journal of Pharmaceutical Sciences, vol. 5, no. 1, June 2018, pp. 41-58, https://doi.org/10.5281/.